The parallel session would like to follow the theme of the IEID conference "Innovation-Empowering Emerging Technologies and Industries". And we will invite domestic and foreign experts and scholars, including innovative entrepreneurs, government officials and other insightful people with international influence in the field of biomedicine, to discuss major technological innovations. The success of the conference will promote the development of the innovative pharmaceutical industry. This year's parallel session will focus on advanced developments of medical devices, artificial intelligence, digestive endoscopy, and medical imaging. The shift from “pharmaceuticals” to “devices” in this year, reflects that the future vision and blueprint of scientific and technological innovation will lead the efficient and comprehensive development of biomedicine.

With the gradual deepening of the reform of the national medical and health system, and the successive introduction of various industrial policies, China has become the world's second largest medical device market, and gives Chinese medical device companies space and time for innovation. The parallel session will not only invite academicians and experts from the United States, Japan, Australia, Austria and other countries to report the latest developments in the field of medical technology and medical devices, but also invite outstanding domestic entrepreneurs such as Ankon Medical and United Imaging to give reports. The content of the reports highlight innovation, comprehensiveness and forward-looking, and emphasize "original" and "domestic".